PBRM1 and cancer: Furthermore, by mapping cancer missense mutations across the protein sequence, which largely follows domain architecture (Fig. 1C), we found that, despite comprising only 6% of the overall protein sequence, the BD4 harbors 10% of all cancer-associated PBRM1 missense mutations.